MedTrace Logo

Trial of Toothpaste to Reduce Plaque and Inflammation

NCT02666508 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2021-01-14

Study results available
· View outcomes & findings →

Summary

Dental plaque causes caries and periodontal disease and data are sparse about toothpaste and plaque removal. Inflammation, caused by dental plaque, is a risk factor for cardiovascular disease. (CVD) The availability of (Plaque HD (TM), a plaque identifying toothpaste with targetol technology (TM)), afforded the unique opportunity to test whether there were statistically significant and clinically important reductions in plaque and inflammation in a randomized trial of apparently healthy individuals.

Conditions

Interventions

OTHER

Plaque identifying toothpaste

Plaque identifying toothpaste with targetol

OTHER

Non-plaque identifying toothpaste

Non-plaque identifying toothpaste without targetol

Sponsors & Collaborators

  • Florida Atlantic University

    collaborator OTHER

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Kimberly Fasula, MS · University of Illinois at Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2016-04-01
Completion
2016-08-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02666508 on ClinicalTrials.gov